loader2
Partner With Us NRI

ERIS Lifesciences Ltd share Price Today

Company details

1,031.80
1,050.70
660.00
1,066.30
6M Return 19.20%
1Y Return 53.92%
Mkt Cap.(Cr) 14,186.36
Volume 51,485
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 51,485
NSE

Invest in Market with Confidence: High performance strike rate of over 72%

Trade, sell, withdraw – all in minutes!
icon 27 Years

of legacy

icon 4.4 Star

App Rating

icon 1 Crore +

Customers

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number
Get Started

Pharmaceuticals firm Eris Lifesciences announced Q4FY23 & FY23 results:

  • Organic standalone revenue growth - 11.5% (Q4), 9.5% (FY23) & 15.6% (FY23)
  • Consolidated Revenue growth at Rs 4,028 million - 32% (Q4), 25% (FY23), and 31% (FY23)
  • Top-20 Eris mother brands accounting for 70% of revenue grew organically by 17% in FY23
  • Eris MJ (Insulin Business) organically clocks Rs 17 crore revenue in first year of commercial operations
  • Achieved organic growth of 22% in Oaknet base business after 3 flat years during FY20-FY22; full year FY23 Revenue Rs 250 crore (28% growth) with EBIDTA Rs 61 crore (margin 24.4%)
  • Amortisation of Glenmark & DRL brands has been charged for 6 months of FY23 as per statutory requirements; however financial upside from the deals has been minimal during FY23 since the deals were consummated in Q4FY23

 

 

 

Result PDF

View Other Company Results

ERIS Lifesciences Ltd shares SWOT Analysis

Strengths (5)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Rising Net Cash Flow and Cash from Operating activity
  • Book Value per share Improving for last 2 years

Weakness (5)

  • Promoters increased pledged shares QoQ
  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years

Opportunity (1)

  • RSI indicating price strength

Threats (1)

  • Increasing Trend in Non-Core Income
Discover More

Resistance and support

R1 1,051.8
R2 1,060.7
R3 1,070.7
Pivot

1,041.80

S1 1,032.9
S2 1,022.9
S3 1,014.0
EMA SMA
981.9
933.2
906.1
870.1
967.5
912.2
893.4
886.7
Delivery and volume
Discover More
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
BHIKHALAL CHIMANLAL SHAH Bulk Sell 2024-01-31 913.09 1280000 BSE
BHIKHALAL CHIMANLAL SHAH Bulk Sell 2024-01-31 912.5 820000 NSE
PLUTUS WEALTH MANAGEMENT LLP Bulk Purchase 2023-07-31 783.03 1210000 NSE
Discover More
Name Category Shares
Amit Indubhushan Bakshi PROMOTER 42.88%
Inderjeet Singh Negi PROMOTER 4.37%
Rajendrakumar Rambhai Patel PROMOTER 4.37%
Kaushal Kamleshkumar Shah PROMOTER 3.29%

FINANCIALS

Sales
Operating Profit
Profit after Tax
DISCOVER MORE
Equity
Reserves and Surplus
Debt
DISCOVER MORE
Sales
Operating Profit
Profit after Tax
DISCOVER MORE
PE
Debt/Equity
P BV
DISCOVER MORE

ERIS Lifesciences Ltd Stocks COMPARISON

Financials( ₹ in Cr) ERIS Lifesciences Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 1,042.90 1,467.25 1,541.55 4,522.15 1,085.05
% Change 1.08 -0.25 -0.21 0.40 -0.33
Mcap ₹ Cr 14,186.36 3,52,042.43 1,24,459.66 1,20,049.06 1,09,181.42
Revenue TTM ₹ Cr 1,685.15 43,885.68 22,753.12 7,767.51 17,237.40
Net Profit TTM ₹ Cr 374.16 8,560.84 2,835.49 1,823.38 1,997.30
PE TTM 36.14 35.16 29.22 74.99 28.33
1 Year Return 53.92 47.92 52.46 26.81 95.14
ROCE 16.69 16.79 17.79 19.30 16.25
ROE 18.23 16.46 12.82 14.89 14.05
DISCOVER MORE
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 2,195.99 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 34,841.27 9,567.52
LAST 3M 1,07,380.98 -15,756.42
LAST 6M 1,82,851.12 -2,333.61
LAST 12M 2,96,057.08 99,791.83

ERIS Lifesciences Ltd Information

Stock PE (TTM)
36.14
Promoter Holding
54.9%
Book Value
190.0829
ROCE
16.69%
ROE
18.23%
Registered Address

8th Floor Commerce House -IV, Prahladnagar 100 FT Road, Ahmedabad, Gujarat, 380015

Tel : 91-79-30451000
Email : complianceofficer:erislifesciences.com
Website : http://www.eris.co.in
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 540596
NSE Code : ERIS
Book Closure Date (Month) : Sep
BSE Group : A
ISIN : INE406M01024

FAQ’s on ERIS Lifesciences Ltd Shares

You can buy ERIS Lifesciences Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy ERIS Lifesciences Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 21, 2024 03:55 PM the closing price of ERIS Lifesciences Ltd was Rs.1,042.90.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 21, 2024 03:55 PM, the market cap of ERIS Lifesciences Ltd stood at Rs. 14,186.36 Cr.

The latest PE ratio of ERIS Lifesciences Ltd as of Jun 21, 2024 03:55 PM is 36.14

The latest PB ratio of ERIS Lifesciences Ltd as of Jun 21, 2024 03:55 PM is 0.18

The 52-week high of ERIS Lifesciences Ltd share price is Rs. 1,066.30 while the 52-week low is Rs. 660.00

According to analyst recommendations, ERIS Lifesciences Ltd Share has a "" rating for the long term.

Download App

Download Our App

Play Store App Store
market app

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number
Get Started
Open a Trading Account